Literature DB >> 19056102

The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus.

Anne-Claire Bréhin1, Isabelle Casadémont, Marie-Pascale Frenkiel, Cécile Julier, Anavaj Sakuntabhai, Philippe Desprès.   

Abstract

Chikungunya virus (CHIKV) becomes one of the most important mosquito-borne alphavirus in the medical field. CHIKV is highly sensitive to antiviral activity of Type-I interferons (IFN-alpha/beta). Here, we investigated the role of IFN-induced 2',5'-Oligoadenylate Synthetase (OAS) family in innate immunity to CHIKV. We established inducible human epithelial HeLa cell lines expressing either the large form of human OAS, OAS3, or the genetic variant OAS3-R844X which is predicted to lack about 20% of the OAS3 protein from the carboxy terminus. HeLa cells respond to ectopic OAS3 expression by efficiently inhibiting CHIKV growth. The characteristic of the antiviral effect was a blockade in early stages of virus replication. Thus, OAS3 pathway may represent a novel antialphaviral mechanism by which IFN-alpha/beta controls CHIKV growth. HeLa cells expressing the truncated form of OAS3 were less resistant to CHIKV infection, raising the question on the involvement of OAS3 genetic polymorphism in human susceptibility to alphavirus infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056102     DOI: 10.1016/j.virol.2008.10.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Proteomic cornerstones of hematopoietic stem cell differentiation: distinct signatures of multipotent progenitors and myeloid committed cells.

Authors:  Daniel Klimmeck; Jenny Hansson; Simon Raffel; Sergey Y Vakhrushev; Andreas Trumpp; Jeroen Krijgsveld
Journal:  Mol Cell Proteomics       Date:  2012-03-27       Impact factor: 5.911

2.  Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.

Authors:  Cheng Xu; Tz-Chun Guo; Stephen Mutoloki; Øyvind Haugland; Inderjit S Marjara; Øystein Evensen
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

3.  The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.

Authors:  Mikkel Søes Ibsen; Hans Henrik Gad; Karthiga Thavachelvam; Thomas Boesen; Philippe Desprès; Rune Hartmann
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

4.  Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.

Authors:  Yize Li; Shuvojit Banerjee; Yuyan Wang; Stephen A Goldstein; Beihua Dong; Christina Gaughan; Robert H Silverman; Susan R Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 5.  Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.

Authors:  Julie M Fox; Michael S Diamond
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

Review 6.  Biology and pathogenesis of chikungunya virus.

Authors:  Olivier Schwartz; Matthew L Albert
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

Review 7.  Chikungunya: a potentially emerging epidemic?

Authors:  Michelle M Thiboutot; Senthil Kannan; Omkar U Kawalekar; Devon J Shedlock; Amir S Khan; Gopalsamy Sarangan; Padma Srikanth; David B Weiner; Karuppiah Muthumani
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

8.  Interferon regulated gene (IRG) expression-signature in a mouse model of chikungunya virus neurovirulence.

Authors:  Sreeja R Nair; Rachy Abraham; Sankar Sundaram; Easwaran Sreekumar
Journal:  J Neurovirol       Date:  2017-10-24       Impact factor: 2.643

9.  Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.

Authors:  Parveen Kaur; Meerra Thiruchelvan; Regina Ching Hua Lee; Huixin Chen; Karen Caiyun Chen; Mah Lee Ng; Justin Jang Hann Chu
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

10.  Common genetic variants and risk for HPV persistence and progression to cervical cancer.

Authors:  Sophia S Wang; Paula Gonzalez; Kai Yu; Carolina Porras; Qizhai Li; Mahboobeh Safaeian; Ana Cecilia Rodriguez; Mark E Sherman; Concepcion Bratti; Mark Schiffman; Sholom Wacholder; Robert D Burk; Rolando Herrero; Stephen J Chanock; Allan Hildesheim
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.